Najat Khan Recursion Pharmaceuticals, Inc. (RXRX) insider trading activity
Najat Khan is Chief R&D Commercial Officer of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 611,135 shares of RXRX, which is worth approximately $2.53 Million. The most recent transaction as insider was on Dec 22, 2025, when has been sold 124,403 shares (Class A Common Stock) at a price of $4.41 per share, resulting in proceeds of $548,617. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
611K
8.54%
3M change
22.97%
12M change
Total Value Held
$2.53 Million
Najat Khan Transaction History
NK
Najat Khan
Chief R&D Commercial Officer
Salt Lake City, UT